Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA)

NCT05181969 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT05181969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05181969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA)
Lead sponsor
Technische Universität Dresden
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2014
Completion date
December 31, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apheresis related complication, cardiovascular diseases, lipoproteinemia